CPRX - Company ID 0001369568
CATALYST PHARMACEUTICALS, INC. (CPRX) reported revenue of $588.99M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $588.99M | +19.8% |
| FY 2024 | $491.73M | +23.5% |
| FY 2023 | $398.20M | +85.9% |
| FY 2022 | $214.20M | +52.1% |
| FY 2021 | $140.83M | +18.3% |
| FY 2020 | $119.07M | +16.4% |
| FY 2019 | $102.31M | +20361.3% |
| FY 2018 | $500.00K | - |
| FY 2017 |
CATALYST PHARMACEUTICALS, INC. (CPRX) reported revenue of $588.99M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, CATALYST PHARMACEUTICALS, INC.'s revenue grew from $0.00 to $588.99M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $0.00 |
| - |
| FY 2016 | $0.00 | - |
| FY 2015 | $0.00 | - |
| FY 2014 | $0.00 | - |
| FY 2013 | $0.00 | - |
| FY 2012 | $0.00 | - |